Panoptica's Series B Round

Panoptica raised a round of funding on April 15, 2014.

PanOptica is a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies. PanOptica has identified and evaluated more than 200 biopharmaceutical assets w…

Articles about Panoptica's Series B Round: